Cargando…

Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia

3′,5′-cyclic guanosine monophosphate (cGMP) is a druggable second messenger regulating cell growth and survival in a plethora of cells and disease states, many of which are associated with hypoxia. For example, in myocardial infarction and heart failure (HF), clinical use of cGMP-elevating drugs imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bork, Nadja I., Kuret, Anna, Cruz Santos, Melanie, Molina, Cristina E., Reiter, Beate, Reichenspurner, Hermann, Friebe, Andreas, Skryabin, Boris V., Rozhdestvensky, Timofey S., Kuhn, Michaela, Lukowski, Robert, Nikolaev, Viacheslav O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590074/ https://www.ncbi.nlm.nih.gov/pubmed/34763298 http://dx.doi.org/10.1016/j.redox.2021.102179

Ejemplares similares

cGMP Signaling in the Cardiovascular System—The Role of Compartmentation and Its Live Cell Imaging
por: Bork, Nadja I., et al.
Publicado: (2018)

cGMP kinase I regulates glucagon release
por: Leiss, Veronika, et al.
Publicado: (2009)

The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009)

Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Publicado: (1984)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

A novel pathway of cGMP
por: Kuhn, Michaela, et al.
Publicado: (2011)

cGMP Signaling, Phosphodiesterases and Major Depressive Disorder
por: Reierson, Gillian W, et al.
Publicado: (2011)

Modulation of cGMP/cAMP crosstalk on the level of PDE3 in animals lacking NO-sensitive guanylyl cyclase
por: Friebe, Andreas, et al.
Publicado: (2015)

Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk
por: Kurelic, Roberta, et al.
Publicado: (2021)

cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
por: Friebe, Andreas, et al.
Publicado: (2019)

Rescue of cGMP kinase I and the cause of premature death
por: Hofmann, Franz, et al.
Publicado: (2009)

In situ cGMP phosphodiesterase and photoreceptor potential in gecko retina
Publicado: (1986)

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)

Cyclic GMP signaling and mitochondrial BK channels in cardioprotection against ischemia/reperfusion injury
por: Frankenreiter, Sandra, et al.
Publicado: (2015)

Direct visualization of cGMP microdomains in adult cardiomyocytes
por: Subramanian, Hariharan, et al.
Publicado: (2015)

The cGMP-phosphodiesterase and its contribution to sensitivity regulation in retinal rods
Publicado: (1995)

Biophysical Techniques for Detection of cAMP and cGMP in Living Cells
por: Sprenger, Julia U., et al.
Publicado: (2013)

The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report
por: Friebe, Andreas, et al.
Publicado: (2023)

The role of cGMP-cGKI-signaling for duodenal bicarbonate secretion
por: Spiessberger, Beate, et al.
Publicado: (2011)

Role of NO/cGMP signalling in VEGF-mediated angiogenesis
por: Jäger, Ronald, et al.
Publicado: (2011)

Compartmentation of cGMP Signaling in Induced Pluripotent Stem Cell Derived Cardiomyocytes during Prolonged Culture
por: Faleeva, Maria, et al.
Publicado: (2022)

PDE3 is the major cGMP-PDE in adult mouse ventricular cardiomyocytes
por: Götz, Konrad R, et al.
Publicado: (2013)

Rapid nitric oxide–induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme
por: Mullershausen, Florian, et al.
Publicado: (2001)

It takes two transducins to activate the cGMP-phosphodiesterase 6 in retinal rods
por: Qureshi, Bilal M., et al.
Publicado: (2018)

Determination of basal phosphodiesterase activity in mouse rod photoreceptors with cGMP clamp
por: Turunen, Teemu T., et al.
Publicado: (2019)

The role of cGMP-cGKI-signaling for duodenal bicarbonate secretion
por: Spiessberger, Beate, et al.
Publicado: (2009)

β(3)-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes
por: Schobesberger, Sophie, et al.
Publicado: (2020)

cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway
por: Park, Min, et al.
Publicado: (2018)

Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases
por: Kopra, Kari, et al.
Publicado: (2020)

Meeting report of the 8(th) International Conference on cGMP “cGMP: generators, effectors, and therapeutic implications” at Bamberg, Germany, from June 23 to 25, 2017
por: Friebe, Andreas, et al.
Publicado: (2017)

cGMP kinase I, cardiac hypertrophy and PDE inhibition
por: Patrucco, Enrico, et al.
Publicado: (2011)

Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide
por: Harms, John F., et al.
Publicado: (2019)

Plasticity and therapeutic potential of cAMP and cGMP-specific phosphodiesterases in Toxoplasma gondii
por: Vo, Kim Chi, et al.
Publicado: (2022)

Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
por: Pavlaki, Nikoleta, et al.
Publicado: (2018)

Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia
por: Monfort, Pilar, et al.
Publicado: (2005)

Cardiac cGMP/cGMP-dependent protein kinase I signalling requires cysteine-rich LIM-only protein 4 (CRP4) to oppose angiotensin II induced hypertrophy and fibrosis
por: Straubinger, Julia, et al.
Publicado: (2013)

cGMP-Phosphodiesterase Inhibition Enhances Photic Responses and Synchronization of the Biological Circadian Clock in Rodents
por: Plano, Santiago A., et al.
Publicado: (2012)

Asymmetric properties of rod cGMP Phosphodiesterase 6 (PDE6): structural and functional analysis
por: Qureshi, Bilal M, et al.
Publicado: (2015)

Phosphodiesterase 9A Controls Nitric-oxide Independent cGMP and Hypertrophic Heart Disease
por: Lee, Dong I., et al.
Publicado: (2015)

Short- and Long-Term Effects of UVA on Arabidopsis Are Mediated by a Novel cGMP Phosphodiesterase
por: Isner, Jean-Charles, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9t3p7508quem12bjopam0aft9l